两项机构前瞻性临床试验中接受四维计算机断层扫描通气功能规避放疗的肺癌患者肺功能检查变化特征
一项2期多中心前瞻性研究评估基于四维计算机断层扫描通气的功能规避放疗,56例局部晚期肺癌患者接受放化疗,基线至治疗后3个月DLCO平均变化-11.6%±14.2%、FEV1 -5.6%±16.9%、FVC -9.0%±20.1%,发生≥2级放射性肺炎者DLCO与FEV1下降数值更大但未达统计学显著,作者定性认为功能规避较标准胸部放疗规划DLCO与FEV1下降更少。
要点
- 56例可评估患者放化疗后3个月DLCO平均下降11.6%、FEV1下降5.6%、FVC下降9.0%。
- ≥2级放射性肺炎者DLCO变化-15.4% vs <2级者-10.8%(P=0.37),未达统计学显著。
- ≥2级放射性肺炎者FEV1变化-14.3% vs <2级者-3.9%(P=0.09),未达统计学显著。
核心结论
- 当前工作是首个在前瞻性功能规避放疗研究中定量描述肺癌患者肺功能检查变化的研究。
- 与接受标准胸部放疗规划的患者相比,数据定性显示功能规避使DLCO与FEV1下降更少。
- 所呈现数据有助于阐明功能规避放疗可能带来的肺功能改善。
研究设计与样本
- 2期多中心前瞻性研究,纳入接受放化疗的局部晚期肺癌患者。
- 基于四维计算机断层扫描通气图像生成功能规避计划。
- 基线及放化疗后3个月获取肺功能检查,比较DLCO、FEV1与FVC变化。
- 56例入组患者具备可分析的基线与治疗后肺功能检查。
主要发现
- DLCO平均变化为-11.6%±14.2%,FEV1为-5.6%±16.9%,FVC为-9.0%±20.1%。
- ≥2级放射性肺炎患者DLCO平均变化-15.4%±14.4% vs <2级患者-10.8%±14.1%(P=0.37)。
- ≥2级放射性肺炎患者FEV1平均变化-14.3%±22.1% vs <2级患者-3.9%±15.4%(P=0.09)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Four-dimensional computed tomography (4DCT)-ventilation-based functional avoidance uses 4DCT images to generate plans that avoid functional regions of the lung with the goal of reducing pulmonary toxic effects. A phase 2, multicenter, prospective study was completed to evaluate 4DCT-ventilation functional avoidance radiation therapy. The purpose of this study was to report the results for pretreatment to posttreatment pulmonary function test (PFT) changes for patients treated with functional avoidance radiation therapy. METHODS AND MATERIALS: Patients with locally advanced lung cancer receiving chemoradiation were accrued. Functional avoidance plans based on 4DCT-ventilation images were generated. PFTs were obtained at baseline and 3 months after chemoradiation. Differences for PFT metrics are reported, including diffusing capacity for carbon monoxide (DLCO), forced expiratory volume in 1 second (FEV1), and forced vital capacity (FVC). PFT metrics were compared for patients who did and did not experience grade 2 or higher pneumonitis. RESULTS: Fifty-six patients enrolled on the study had baseline and posttreatment PFTs evaluable for analysis. The mean change in DLCO, FEV1, and FVC was -11.6% ± 14.2%, -5.6% ± 16.9%, and -9.0% ± 20.1%, respectively. The mean change in DLCO was -15.4% ± 14.4% for patients with grade 2 or higher radiation pneumonitis and -10.8% ± 14.1% for patients with grade <2 radiation pneumonitis (P = .37). The mean change in FEV1 was -14.3% ± 22.1% for patients with grade 2 or higher radiation pneumonitis and -3.9% ± 15.4% for patients with grade <2 radiation pneumonitis (P = .09). CONCLUSIONS: The current work is the first to quantitatively characterize PFT changes for patients with lung cancer treated on a prospective functional avoidance radiation therapy study. In comparison with patients treated with standard thoracic radiation planning, the data qualitatively show that functional avoidance resulted in less of a decline in DLCO and FEV1. The presented data can help elucidate the potential pulmonary function improvement with functional avoidance radiation therapy.
引用
- Miller R, Castillo R, Castillo E, et al. Characterizing Pulmonary Function Test Changes for Patients With Lung Cancer Treated on a 2-Institution, 4-Dimensional Computed Tomography-Ventilation Functional Avoidance Prospective Clinical Trial. Adv Radiat Oncol. 2022. PMID: 36618762. doi:10.1016/j.adro.2022.101133
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。